advanced search
Adrien Tisserand

Is this your profile?

About

Adrien Tisserand is Head of Key Accounts at Bormioli Pharma (Gerresheimer). Until 2022 he was a Key Account  Manager at Nemera and before that he was Global Category Manager, Parenteral & CMO, where he was in charge of Nemera’s parenteral range, having joined Nemera in 2013. In his previous career he worked for Janssen in the strategic marketing division.

Mr Tisserand holds a Bachelors in International Business from HUBS, UK, a Masters in Marketing from URJC, Madrid, Spain, and a Masters from Kedge Business School, France.

Contributions

PREFILLED SYRINGES
COMPLEX DEVICES, SIMPLE PATIENT CARE
Adrien Tisserand explains how the recent granting of German Pharmaceutical Drug Manufacturing Authorisation for Nemera’s facility in Neuenburg enhances the company’s offering to industry, before going on to discuss the Safelia® auto-injector and Safe’n’Sound® safety device platforms.

More contributions

PREFILLED SYRINGES
A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS
William Dierick, Pascal Dugand and Adrien Tisserand describe a collaboration to create a compatibility between Terumo’s PLAJEX™; prefillable syringes with Nemera’s Safe‘n’Sound® platform of add-on passive sharps injury protection devices for PFS.
PREFILLED SYRINGES
COMPANY SHOWCASE: NEMERA (INJECTABLES OFFERING)
Nemera and its partners empower patients through good design with Nemera’s extensive experience in developing and manufacturing parenteral drug delivery devices. Its global centre of expertise comprises more than 60 engineers and experts in creative design and human factors activities.
PREFILLED SYRINGES
ASSESSING THE IMPACT ON DRUG DOSE DELIVERY OF PASSIVE SAFETY DEVICES
Adrien Tisserand reports findings from a comparative study on drug dose delivery of the company’s passive needle-safety platform, Safe’n’Sound®.
Top